LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 72.52 84.90 6596 9214 0.7158 0.9035
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 72.52 84.90 709 9214 0.0769 0.3687
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 72.52 84.90 8294 9214 0.9001 0.9691
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 74.22 84.90 1508 9343 0.1614 0.5284
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 74.22 84.90 6663 9343 0.7131 0.9027
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 74.22 84.90 617 9343 0.0660 0.3397
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 74.22 84.90 8440 9343 0.9033 0.9702
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 75.93 84.90 1644 8970 0.1833 0.5539
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 75.93 84.90 6935 8970 0.7731 0.9249
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 75.93 84.90 657 8970 0.0732 0.3557
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 75.93 84.90 8648 8970 0.9640 0.9891
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 77.64 84.90 1649 9245 0.1784 0.5502
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 77.64 84.90 7132 9245 0.7714 0.9247
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 77.64 84.90 672 9245 0.0727 0.3576
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 77.64 84.90 8853 9245 0.9575 0.9872
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 79.34 84.90 1644 9051 0.1816 0.5526
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 79.34 84.90 7325 9051 0.8093 0.9381
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 79.34 84.90 679 9051 0.0750 0.3616
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 79.34 84.90 9105 9051 1.0059 1.0017
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 81.05 84.90 1766 8863 0.1992 0.5724
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 81.05 84.90 7548 8863 0.8515 0.9526
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 81.05 84.90 619 8863 0.0698 0.3448
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 81.05 84.90 9314 8863 1.0508 1.0148
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 82.75 84.90 1873 8621 0.2173 0.5906
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 82.75 84.90 7779 8621 0.9023 0.9694
MN20160318_Q02
E16